Below is a conversation with bioethics commentator Kelly Hills (who BTW has a great blog), tackling some of the key issues surrounding the potential use of CRISPR-Cas9 technology to make heritable human genetic modification. I really appreciate her clear and insightful answers to some tough questions that many are grappling with today on this topic. Part […]
Kelly Hills interview: human genetic modification & bioethics Read More »
On Thursday here at UC Davis School of Medicine we held our second annual Stem Cell Ethics Symposium. The symposium was organized by Drs. Mark Yarborough and Nanette Joyce as well as me. In this post I report on key take homes from the meeting and summarize the specific talks. As far as I know, this is one of the few
Meeting review of unique stem cell ethics symposium at UC Davis School of Medicine Read More »
We here at UC Davis School of Medicine are gearing up for our 2nd annual Stem Cell Ethics Symposium (see flyer). As one of the organizers, I’m really excited about our lineup of speakers including Timothy Caulfield, Leigh Turner, Alison Sorkin, Mary Ann Chirba, and Richard Garr as well as others. We will be focusing
UC Davis 2nd Annual Stem Cell Ethics Symposium: Save the Date Feb. 12 Read More »
When bioethicist Arthur Caplan talks about stem cells, people pay close attention and for good reason. Caplan has provided important perspectives on the stem cell field over the years. For example, you can see a guest post on this blog here about human cloning. However, in my post today I respectfully discuss how I disagree with several parts of this week’s piece by
Arthur Caplan Article on Bogus Stem Cell Research: Some Different Views Read More »
It was my pleasure recently to talk at length with Dr. Michael West, CEO of the Stem Cell Biotech, BioTime (BTX). West has been at the helm of BioTime since 2007 and is a true pioneer in the stem cell field. He founded Geron (GERN) and was a top leader at Advanced Cell Technology (ACT; stock
Interview with BioTime CEO Michael West Part 1: a little stem cell history Read More »
What are Conflict of Interests (COI)? The term COI is sometimes used inappropriately as a weapon by one party to attempt to discredit others. We see this more and more frequently in the stem cell field with boosters of for-profit, non-FDA vetted adult stem cell clinics attacking scientists for supposed COIs for what…..apparently for simply
Real and imaginary conflicts of interest: a helpful guide Read More »
Today after years of following the company Advanced Cell Technology (ACT), I finally bought stock (ACTC) in it. Why? As a stem cell researcher myself working on human ES cells, iPS cells, and many other types of stem cells, I have been following ACT for years, but have never pulled the trigger to buy their stock….until
Why I finally bought stock in Advanced Cell Technology Read More »